• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

PAR South Will Be Sold Off

Quote

Will PAR South Huntsville Site Shuts down or be Sold Off?

  • Shutdown

    Votes: 0 0.0%

  • Sold Off

    Votes: 0 0.0%

  • Or be used used to make minimal beer money for executives

    Votes: 0 0.0%
  • Total voters
    0
  • Poll closed .
Top Levels in Huntsville be ready in the weeks to come you will unfortunately be on the unemployment line. Please don't be upset, just know you can blame it on the Sales Team.
 








anonymous said:
Seems like everyone understands the issue is the sales the team. Paul / Terry when will guys realize that we need the power house sales team we use to have.... Imagine the amount of the PAR Legacy products in which could be sold.
Click to expand...

The company wouldn't be going under that's for sure. The old sales team actually asked for business.
 
















Green Bills said:
If cost savings is the whole key of the new company mind set, why aren't multiple sites products sent to the Huntsville site to be manufactured and packaged since they have the capacity and the state of the art equipment to complete in high speeds and volumes?
Click to expand...


Because state of the art equipment only works if you have people smart enough to run it,,
 




When the Huntsville site shuts down, you guys can all get together and run a moonshine operation. Look at it this way, a bottle of shine sells for more than a bottle any of your current products!! Yeeeeeee Hawwwwww!!!!
 












Perrigo is buying Endo and all generics will be run by Par. Here we go again, more generic products that won't be sold due to the inability of the current sales force to sale candy to a child!
 












It will be interesting to see when the Town Hall discussions are scheduled for. Bet they are very selective on the what they say. Hope someone asks why we do not changes our current sales practices.
 




PAR hated that they had to be merged with Qualitest because they wouldn't be able to be top dogs. Par margins were not superior to the Legacy Qualitest business. Legacy was audited by the same company auditors as the current ones and had comparable margins to Par. Legacy business WAS worth same amount as Par. So how did they become Top dogs again, refuse to sale our products after firing our entire sales force...
 




















Looks to be PAR was in a large amount of debt prior to ENDO purchasing them and now with what the Sales Force has been able to do we will just keep on increasing the size of our debt. You would think they would understand now that you have to sell drug to make money. The buyers will not come to you to buy!

The company announced in May that it would be acquired by Endo International for $8.05 billion. The acquisition price, which assumes the company's $2.3 billion of debt, is 81% in cash and 19% in stock.

The ENDO board must have just taken a vacation to California and was still smoking the good stuff....
 




Top Bottom
Back
Quote